Immunochemotherapy With Rituximab-Bendamustine-Cytarabine (R-BAC) for Patients With Mantle Cell Lymphoma

Clinical trial NCT00992134 · COMPLETED

Trial details

NCT number: NCT00992134
Sponsor: St. Bortolo Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Mantle-Cell

Start date: 2009-06-01
Primary completion: 2011-06-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.